Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: EXTREME DIZZINESS UPON EXERTION; LOSS OF APPETITE; HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Q07AQ1A expiry: UNKNOWN) dose was not reported, administered on 04-MAY-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 04-MAY-2021, the subject experienced fatigue. On 05-MAY-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99.1 F. On 07-MAY-2021, the subject experienced extreme dizziness upon exertion. On 07-MAY-2021, the subject experienced loss of appetite. On 07-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and had not recovered from fatigue, headache, loss of appetite, and extreme dizziness upon exertion. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166